Deep Learning-Based Proarrhythmia Analysis Using Field Potentials Recorded From Human Pluripotent Stem Cells Derived Cardiomyocytes
暂无分享,去创建一个
Hamid R. Rabiee | Mahdieh Soleymani Baghshah | Zeinab Golgooni | Sara Mirsadeghi | Pedram Ataee | Hossein Baharvand | Sara Pahlavan | H. Rabiee | H. Baharvand | S. Pahlavan | P. Ataee | Zeinab Golgooni | Sara Mirsadeghi | Mahdieh Soleymani Baghshah
[1] Luca Sala,et al. Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs) , 2017, Journal of visualized experiments : JoVE.
[2] Nick Thomas,et al. High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[3] Bram van Ginneken,et al. A survey on deep learning in medical image analysis , 2017, Medical Image Anal..
[4] Liang Guo,et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[5] Nitish Srivastava,et al. Dropout: a simple way to prevent neural networks from overfitting , 2014, J. Mach. Learn. Res..
[6] Philip Wong,et al. Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[7] S. Heilmann-Heimbach,et al. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2. , 2016, Stem cell research.
[8] Jürgen Schmidhuber,et al. Long Short-Term Memory , 1997, Neural Computation.
[9] Mike Clements,et al. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[10] David G Strauss,et al. Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA. , 2017, Journal of electrocardiology.
[11] Sergey Ioffe,et al. Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift , 2015, ICML.
[12] K. Aalto-Setälä,et al. Cardiomyocyte MEA Data Analysis (CardioMDA) – A Novel Field Potential Data Analysis Software for Pluripotent Stem Cell Derived Cardiomyocytes , 2013, PloS one.
[13] Michael A. Arbib,et al. The handbook of brain theory and neural networks , 1995, A Bradford book.
[14] Lior Gepstein,et al. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. , 2009, Stem cells and development.
[15] P. Sager,et al. Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study , 2017, Clinical pharmacology and therapeutics.
[16] H. Baharvand,et al. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells. , 2010, Biochemical and biophysical research communications.
[17] Ronald A. Li,et al. Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells , 2017, eLife.
[18] C. Mummery,et al. Human stem cell models for predictive cardiac safety pharmacology. , 2010, Stem cell research.
[19] Hossein Baharvand,et al. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells , 2015, Stem cells translational medicine.
[20] R. Passier,et al. Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes , 2017, Biochemical and biophysical research communications.
[21] Liang Guo,et al. Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[22] Hugh S Markus,et al. Personalized medicine: risk prediction, targeted therapies and mobile health technology , 2014, BMC Medicine.
[23] H. Krumholz. Big data and new knowledge in medicine: the thinking, training, and tools needed for a learning health system. , 2014, Health affairs.
[24] Gary Gintant,et al. The Evolving Roles of Human iPSC-Derived Cardiomyocytes in Drug Safety and Discovery. , 2017, Cell stem cell.
[25] H. Baharvand,et al. Generation of new human embryonic stem cell lines with diploid and triploid karyotypes , 2006, Development, growth & differentiation.
[26] E. Schulze-Bahr,et al. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction , 2016, Basic Research in Cardiology.
[27] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[28] U. Egert,et al. Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. , 2003, American journal of physiology. Heart and circulatory physiology.
[29] Gary R. Mirams,et al. Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro‐arrhythmia Assay initiative studies , 2017, British journal of pharmacology.
[30] Ville J. Kujala,et al. Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes , 2016, SpringerPlus.
[31] Azra Fatima,et al. In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells , 2011, Cellular Physiology and Biochemistry.
[32] K. Borgwardt,et al. Machine Learning in Medicine , 2015, Mach. Learn. under Resour. Constraints Vol. 3.
[33] Moncef Gabbouj,et al. Personalized Monitoring and Advance Warning System for Cardiac Arrhythmias , 2017, Scientific Reports.
[34] Byunghan Lee,et al. Deep learning in bioinformatics , 2016, Briefings Bioinform..
[35] Amir Lerman,et al. Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. , 2013, Pharmacology & therapeutics.
[36] M. Hayden,et al. Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes , 2016, Scientific Reports.
[37] K. Aalto-Setälä,et al. The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes , 2016, Stem Cell Reviews and Reports.
[38] K. Harris,et al. A Human Induced Pluripotent Stem Cell−Derived Cardiomyocyte (hiPSC‐CM) Multielectrode Array Assay for Preclinical Cardiac Electrophysiology Safety Screening , 2015, Current protocols in pharmacology.
[39] Donald M Bers,et al. Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays , 2013, Circulation.
[40] R. Harvey,et al. Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol. , 2016, Journal of visualized experiments : JoVE.
[41] G. Gintant,et al. Evolution of strategies to improve preclinical cardiac safety testing , 2016, Nature Reviews Drug Discovery.
[42] T. Šarić,et al. Effects of hawthorn (Crataegus pentagyna) leaf extract on electrophysiologic properties of cardiomyocytes derived from human cardiac arrhythmia‐specific induced pluripotent stem cells , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] Tetsuji Itoh,et al. CSAHi study‐2: Validation of multi‐electrode array systems (MEA60/2100) for prediction of drug‐induced proarrhythmia using human iPS cell‐derived cardiomyocytes: Assessment of reference compounds and comparison with non‐clinical studies and clinical information , 2017, Regulatory toxicology and pharmacology : RTP.
[44] Alex Graves,et al. Supervised Sequence Labelling , 2012 .
[45] M. Morad,et al. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. , 2013, Cell calcium.
[46] A. Su,et al. Harnessing the heart of big data. , 2015, Circulation research.